Use of faecal immunochemical testing as an alternative to faecal calprotectin in children

Kirn Sandhu1, Sandhia Naik1, Ruth M Ayling2

  • 1Department of Paediatric Gastroenterology, Barts Health NHS Trust, London, UK.

Insights

Faecal haemoglobin is a reliable non-invasive marker for intestinal inflammation in children, correlating well with faecal calprotectin. Elevated faecal haemoglobin levels can help rule out significant bowel disease in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Diagnostics
  • Biomarker Research

Background:

  • Faecal calprotectin is a standard non-invasive marker for pediatric intestinal inflammation.
  • Faecal haemoglobin testing (FOBT) is established in adults for colorectal cancer screening and monitoring inflammatory bowel disease.
  • The utility of FOBT in pediatric populations for assessing bowel disease has not been extensively studied.

Purpose of the Study:

  • To evaluate the performance of faecal haemoglobin (FOBT) in children with bowel symptoms.
  • To compare the diagnostic accuracy of FOBT with faecal calprotectin in a pediatric cohort.
  • To determine if FOBT can serve as a reliable indicator of significant bowel disease in children.

Main Methods:

  • Prospective collection of faecal samples from children in a pediatric gastroenterology clinic over 10 months.
  • Simultaneous measurement of faecal haemoglobin using OC-Sensor and faecal calprotectin using Liason®Calprotectin.
  • Correlation analysis (Spearman's rank) and comparison of results with histological findings from colonoscopies.

Main Results:

  • A significant positive correlation was observed between faecal haemoglobin and faecal calprotectin (Spearman's rho = 0.656, P < 0.0001).
  • Faecal haemoglobin levels >20 μg/g were associated with significant histological inflammation, with 32 out of 35 such patients also having elevated faecal calprotectin (>200 μg/g).
  • A faecal haemoglobin level <4 μg/g was indicative of normal histology.

Conclusions:

  • This study is the first to directly compare faecal haemoglobin and faecal calprotectin in pediatric patients.
  • Faecal haemoglobin demonstrates a strong correlation with faecal calprotectin in children, suggesting its potential as a non-invasive biomarker.
  • Faecal haemoglobin >20 μg/g is a reliable indicator of significant bowel inflammation in pediatric patients, supporting its use in ruling out significant bowel disease.
Abstract